Search Results - "LIEDKE, Pedro E. R"
-
1
Breast cancer in Mexico: a growing challenge to health and the health system
Published in The lancet oncology (01-08-2012)“…Summary Breast cancer is a major public health issue in low-income and middle-income countries. In Mexico, incidence and mortality of breast cancer have risen…”
Get full text
Journal Article -
2
Breast cancer in Brazil: present status and future goals
Published in The lancet oncology (01-03-2012)“…Summary Breast cancer is the most common cancer in women worldwide and 70% of breast cancer deaths occur in women from low-income and middle-income countries…”
Get full text
Journal Article -
3
Progress and remaining challenges for cancer control in Latin America and the Caribbean
Published in The lancet oncology (01-10-2015)“…Summary Cancer is one of the leading causes of mortality worldwide, and an increasing threat in low-income and middle-income countries. Our findings in the…”
Get full text
Journal Article -
4
Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial
Published in Journal of clinical oncology (10-04-2013)“…In patients with hormone-dependent postmenopausal breast cancer, standard adjuvant therapy involves 5 years of the nonsteroidal aromatase inhibitors…”
Get full text
Journal Article -
5
Outcomes of Breast Cancer in Brazil Related to Health Care Coverage: A Retrospective Cohort Study
Published in Cancer epidemiology, biomarkers & prevention (2014)“…Breast cancer is the most common malignancy in women in Brazil. Differences between patients with public versus private healthcare coverage about general…”
Get full text
Journal Article -
6
Aromatase inhibitors and musculoskeletal adverse events
Published in The lancet oncology (01-04-2012)Get full text
Journal Article -
7
Access to care issues adversely affect breast cancer patients in Mexico: oncologists' perspective
Published in BMC cancer (09-09-2014)“…Despite recently implemented access to care programs, Mexican breast cancer (BC) mortality rates remain substantially above those in the US. We conducted a…”
Get full text
Journal Article -
8
Challenges to effective cancer control in China, India, and Russia
Published in The lancet oncology (01-04-2014)“…Summary Cancer is one of the major non-communicable diseases posing a threat to world health. Unfortunately, improvements in socioeconomic conditions are…”
Get full text
Journal Article -
9
Cancer control in Latin America and the Caribbean: recent advances and opportunities to move forward
Published in The lancet oncology (01-11-2021)“…The increasing burden of cancer represents a substantial problem for Latin America and the Caribbean. Two Lancet Oncology Commissions in 2013 and 2015…”
Get full text
Journal Article -
10
Differences in Breast Cancer Stage at Diagnosis by Ethnicity, Insurance Status, and Family Income in Young Women in the USA
Published in Journal of racial and ethnic health disparities (01-10-2019)“…Purpose Describe the clinical and epidemiological data from young women with breast cancer and determine the association between ethnicity, insurance status,…”
Get full text
Journal Article -
11
Extended adjuvant endocrine therapy in hormone dependent breast cancer: The paradigm of the NCIC-CTG MA.17/BIG 1–97 trial
Published in Critical reviews in oncology/hematology (01-04-2013)“…Abstract Early hormone-receptor-positive breast cancer is a chronic relapsing disease that can remain clinically silent for many years. The NCIC-CTG MA.17/BIG…”
Get full text
Journal Article -
12
Treatment-associated musculoskeletal and vasomotor symptoms and relapse-free survival in the NCIC CTG MA.27 adjuvant breast cancer aromatase inhibitor trial
Published in Journal of clinical oncology (20-01-2015)“…Treatment-emergent symptoms with adjuvant tamoxifen and aromatase inhibitors (AIs) have been associated with superior recurrence-free survival (RFS). We…”
Get full text
Journal Article -
13
Neutropenia Prevention in the Treatment of Post-docetaxel Metastatic, Castration-resistant Prostate Cancer With Cabazitaxel and Prednisone: A Multicenter, Open-label, Single-arm Phase IV Study
Published in Clinical genitourinary cancer (01-06-2021)“…Severe neutropenia is a dose-limiting factor that occurs in up to 82% of patients with metastatic castration-resistant prostate cancer (mCRPC) treated with…”
Get full text
Journal Article -
14
Advanced Stage at Diagnosis and Worse Clinicopathologic Features in Young Women with Breast Cancer in Brazil: A Subanalysis of the AMAZONA III Study (GBECAM 0115)
Published in Journal of global oncology (01-11-2019)“…Breast cancer (BC) in young women is uncommon and tends to present with more aggressive characteristics. To better understand and characterize this scenario in…”
Get full text
Journal Article -
15
Planning cancer control in Latin America and the Caribbean
Published in The lancet oncology (01-04-2013)“…Summary Non-communicable diseases, including cancer, are overtaking infectious disease as the leading health-care threat in middle-income and low-income…”
Get full text
Journal Article -
16
Reply to e. Esin et al
Published in Journal of clinical oncology (20-09-2013)Get full text
Journal Article -
17
Intermittent Letrozole Therapy for Metastatic Breast Cancer: Case Reports and Literature Review
Published in Clinical breast cancer (01-04-2014)Get full text
Journal Article